These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30321288)

  • 1. Breast cancer cell-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells.
    Hao S; Chen X; Wang F; Shao Q; Liu J; Zhao H; Yuan C; Ren H; Mao H
    Carcinogenesis; 2018 Dec; 39(12):1488-1496. PubMed ID: 30321288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated level of interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3.
    Ma Y; Chen L; Xie G; Zhou Y; Yue C; Yuan X; Zheng Y; Wang W; Deng L; Shen L
    Oncotarget; 2016 Nov; 7(45):73003-73015. PubMed ID: 27682874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased tumor-infiltrating CD45RA
    Mao FY; Kong H; Zhao YL; Peng LS; Chen W; Zhang JY; Cheng P; Wang TT; Lv YP; Teng YS; Fu XL; Liu YG; Wu XL; Hao CJ; You N; Luo P; Yu PW; Zou QM; Guo G; Zhuang Y
    Cell Death Dis; 2017 Aug; 8(8):e3002. PubMed ID: 28817117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.
    Schneider R; Yaneva T; Beauseigle D; El-Khoury L; Arbour N
    Eur J Immunol; 2011 Jan; 41(1):47-59. PubMed ID: 21182076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro.
    Li X; Tian L; Dong Y; Zhu Q; Wang Y; Han W; Liu X; Ni Q; Chen Y; Li L
    Clin Sci (Lond); 2015 Sep; 129(5):395-404. PubMed ID: 25869609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer.
    Ma YF; Chen C; Li D; Liu M; Lv ZW; Ji Y; Xu J
    Oncotarget; 2017 Jan; 8(5):7614-7624. PubMed ID: 27935862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer.
    Chabab G; Barjon C; Abdellaoui N; Salvador-Prince L; Dejou C; Michaud HA; Boissière-Michot F; Lopez-Crapez E; Jacot W; Pourquier D; Bonnefoy N; Lafont V
    J Leukoc Biol; 2020 Jun; 107(6):1057-1067. PubMed ID: 32362028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
    Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
    J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases.
    Egwuagu CE; Yu CR; Sun L; Wang R
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):587-93. PubMed ID: 26279360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human placental trophoblast cells contribute to maternal-fetal tolerance through expressing IL-35 and mediating iT
    Liu J; Hao S; Chen X; Zhao H; Du L; Ren H; Wang C; Mao H
    Nat Commun; 2019 Oct; 10(1):4601. PubMed ID: 31601798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway.
    Liang Y; Chen Q; Du W; Chen C; Li F; Yang J; Peng J; Kang D; Lin B; Chai X; Zhou K; Zeng J
    Mediators Inflamm; 2016; 2016():3214105. PubMed ID: 27247488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients.
    Xydia M; Rahbari R; Ruggiero E; Macaulay I; Tarabichi M; Lohmayer R; Wilkening S; Michels T; Brown D; Vanuytven S; Mastitskaya S; Laidlaw S; Grabe N; Pritsch M; Fronza R; Hexel K; Schmitt S; Müller-Steinhardt M; Halama N; Domschke C; Schmidt M; von Kalle C; Schütz F; Voet T; Beckhove P
    Nat Commun; 2021 Feb; 12(1):1119. PubMed ID: 33602930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
    Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
    J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of interleukin (IL)-21 and CD4
    Alahgholi-Hajibehzad M; Durmuş H; Aysal F; Gülşen-Parman Y; Oflazer P; Deymeer F; Saruhan-Direskeneli G
    Clin Exp Immunol; 2017 Nov; 190(2):201-207. PubMed ID: 28671717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses.
    Shimozato O; Sato A; Kawamura K; Chiyo M; Ma G; Li Q; Tagawa M
    Immunology; 2009 Sep; 128(1 Suppl):e816-25. PubMed ID: 19740343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.
    Gradolatto A; Nazzal D; Truffault F; Bismuth J; Fadel E; Foti M; Berrih-Aknin S
    J Autoimmun; 2014 Aug; 52():53-63. PubMed ID: 24405842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
    Gao X; Wang X; Yang Q; Zhao X; Wen W; Li G; Lu J; Qin W; Qi Y; Xie F; Jiang J; Wu C; Zhang X; Chen X; Turnquist H; Zhu Y; Lu B
    J Immunol; 2015 Jan; 194(1):438-45. PubMed ID: 25429071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancer.
    Heon EK; Wulan H; Macdonald LP; Malek AO; Braunstein GH; Eaves CG; Schattner MD; Allen PM; Alexander MO; Hawkins CA; McGovern DW; Freeman RL; Amir EP; Huse JD; Zaltzman JS; Kauff NP; Meyers PG; Gleason MH; Overholtzer MG; Wiseman SS; Streutker CD; Asa SW; McAlindon TP; Newcomb PO; Sorensen PM; Press OA
    Biochem Biophys Res Commun; 2015 Aug; 464(1):360-6. PubMed ID: 26141233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.